Vinge advises Nordea and SEB in relation to Better Collective’s listing on Nasdaq Stockholm

Vinge advises Nordea Bank AB (publ) and Skandinaviska Enskilda Banken (publ) who are acting as Joint Global Coordinators and Joint Bookrunners in connection with the listing of Better Collective A/S – one of the leading affiliates on the European iGaming affiliate market – on Nasdaq Stockholm.

Vinge has advised Cellink in a directed new issue of shares of MSEK 100

Vinge has advised Cellink AB (publ) in connection with a directed new issue of shares to Swedish and internationally well-reputed investors such as the Swedish Fourth AP Fund (AP4), Carl Bennet AB, Claes Dinkelspiel and Handelsbanken Fonder.

Vinge advises Opus Group in conjunction with issuance of bonds

Opus Group AB (publ) (”Opus”) has issued a so called senior unsecured bond in the amount of MSEK 500 MSEK with a term of four years on the Nordic market.

Vinge advises Active Biotech on rights offering

Active Biotech AB (publ) issues new shares with pre-emptive rights for the shareholders.

Vinge advises Tele2 in the merger with Com Hem

Tele2 AB (publ) and Com Hem Holding AB (publ) announced on 10 January 2018 that they have agreed on a combination through a statutory merger in accordance with the Swedish Companies Act.

Vinge advises Hansa Medical in connection with directed share issue

The board of directors of Hansa Medical has resolved on a directed new issue of ordinary shares, subject to approval by an extraordinary general meeting, whereby Hansa Medical will raise proceeds of approximately SEK 545 million, before issue costs.

Vinge advises Irisity in connection with new issues

Vinge is advising Irisity AB (publ), listed on Nasdaq First North, in connection with a rights issue and a directed new issue of shares.

Vinge advises Surgical Science Sweden AB

Vinge advises Surgical Science Sweden AB in connection with its listing on First North and a related capital increase.

Vinge advises DGC in connection with EQT’s acquisition of shares in DGC and subsequent mandatory offer

Vinge advises DGC One AB (publ) (“DGC”) in connection with EQT’s acquisition of 85.2 percent of the total number of shares and votes in DGC and subsequent mandatory recommended cash offer to the remaining shareholders.

Vinge advises Boozt AB (publ) in connection with its listing on Nasdaq Stockholm

Vinge has advised Boozt AB (publ) (“Boozt”) in connection with its listing on Nasdaq Stockholm.

Vinge advises Medicover in relation to its listing on Nasdaq Staockholm

Vinge advises Medicover AB (publ) (“Medicover”) and its main shareholder Celox Holding AB (“Celox”), which is wholly owned by the charitable foundation the Jonas and Christina af Jochnick Foundation, in relation to Medicover’s listing on Nasdaq Stockholm.

Vinge advises Actic Group AB (publ) in connection with its listing on Nasdaq Stockholm

Vinge has advised Actic Group AB (publ) (”Actic”) in connection with its listing on Nasdaq Stockholm. The prospectus was published on 28 March 2017 and the first day of trading on Nasdaq Stockholm was 7 April 2017.

Vinge has advised SEB in connection with an issue of additional Tier 1 captial of MUSD 600

Vinge has advised Skandinaviska Enskilda Banken AB (publ) (“SEB”) as to Swedish law in connection with the bank’s issue of Additional Tier 1 Capital in the amount of MUSD 600 in the form of a debt instrument with no final maturity and with automatically conversion into Class A-shares if the CET1 ratio of the bank decreases to a certain level.